Kulwinder Kaur
Obstetrics · Fresno, CANPI 1376884809
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations.
Across 194 payments — averaging $13.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$478
- Shield Therapeutics Inc$405
- Therapeuticsmd, Inc.$393
- AbbVie$351
- Sage Therapeutics, LLC$234
- Organon$231
- plus $567 from 11 others
What the payments were for
- Food & beverage$2,64199%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 30 | $478 |
| Shield Therapeutics Inc | 24 | $405 |
| Therapeuticsmd, Inc. | 41 | $393 |
| AbbVie | 32 | $351 |
| Sage Therapeutics, LLC | 26 | $234 |
| Organon | 12 | $231 |
| Coopersurgical, Inc. | 7 | $136 |
| Pfizer | 6 | $104 |
| Myovant Sciences Inc. | 4 | $79 |
| Agile Therapeutics, Inc. | 3 | $63 |
| BD | 2 | $53 |
| Bayer | 2 | $38 |
| Astellas Pharma US Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $12 |
How this compares
$2,658 in reported general payments places this provider in the 80th percentile of 119 obstetrics providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 12 | $3,645 |
| JencyclaNorethindrone | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $104 | $3,64512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 119 obstetrics providers in California.
Other obstetrics in Fresno
- Kelleen BoschFresno$5K
- Ravneet ThindFresno$933
- Peter WangGarden Grove$428K
- Douglas Woelkersla Jolla$57K
- Richard FriedmanBurbank$18K
- Jennifer ByerSanta Rosa$17K
- Omar AzizEl Centro$14K
- Frederica LofquistSan Francisco$14K
- Craig SafferSan Diego$14K
- Caitlyn PainterSan Francisco$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.